Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: A comprehensive review

Journal of Excipients and Food Chemicals

Volumn 1, Issue 3, 2010, Pages 3-26

  Bharate, Sonali S ^a   Bharate, Sandip B ^b   Bajaj, Amrita N ^c  

^a PE Society's Modern College of Pharmacy   (India)

^b SINHGAD COLLEGE OF PHARMACY   (India)

^c SNDT WOMEN S UNIVERSITY   (India)

Author keywords

Active pharmaceutical ingredient; Excipients; Incompatibility; Interaction; Lactose; Magnesium stearate

Indexed keywords

ACECLOFENAC; ALBENDAZOLE; AMLODIPINE; BACLOFEN; BETA LAPACHONE; CALCIUM PHOSPHATE DIBASIC; CAPTOPRIL; CARBONIC ACID; CHITOSAN; CHLORPROPAMIDE; DODECYL SULFATE SODIUM; EUDRAGIT; EXCIPIENT; FLUCONAZOLE; FOSINOPRIL; GLIPIZIDE; MACROGOL; MAGNESIUM OXIDE; MANNITOL; MEGLUMINE; METFORMIN; OMEPRAZOLE; OXPRENOLOL; PEFLOXACIN; POLYSORBATE 80; POVIDONE; RANITIDINE; SILICON DIOXIDE; STEARIC ACID DERIVATIVE; UNINDEXED DRUG;

ACYLATION; ADDITION REACTION; CHEMICAL INTERACTION; DEGRADATION KINETICS; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG FORMULATION; DRUG OXIDATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; EXCIPIENT COMPATIBILITY; GLYCATION; POLYMERIZATION; REVIEW; SOLID STATE; TABLET FORMULATION;

EID: 79952076138     PISSN: None     EISSN: 21502668     Source Type: Journal    
DOI: None     Document Type: Review

References (130)

1. Rowe RC; Sheskey PJ; Quinn ME, Handbook of Pharmaceutical Excipients. 6th Edition ed.; Pharmaceutical Press: London, 2009.
2. Clas SD; Dalton CR; Hancock BC, Differential scanning calorimetry: applications in drug development. Pharm. Sci. Technol. Today 2, 311-320, 1999.
3. Giron D, Contribution of thermal methods and related techniques to the rational development of pharmaceuticals-Part 2. Pharm. Sci. Technol. Today 1, 262-268, 1998.
4. Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE, A New approach to accelerated drug-excipient compatibility testing. Pharm. Dev. Technol. 8, 119-126, 2003.
5. Vueba ML; Veiga F; Sousa JJ; Pina ME, Compatibility studies between ibuprofen or ketoprofen with cellulose ether polymer mixtures using thermal analysis. Drug Dev. Ind. Pharm. 31, 943-949, 2005.
6. Verma RK; Garg S, Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. J. Pharm. Biomed. Anal. 35, 449-458, 2004.
7. Phipps MA; Mackin LA, Application of isothermal microcalorimetry in solid state drug development. Pharm. Sci. Technol. Today 3, 9-17, 2000.
8. Mura P; Faucci MT; Manderioli A; Bramanti G; Ceccarelli L, Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. J. Pharm. Biomed. Anal. 18, (151-163), 1998.
9. Thomas VH; Naath M, Design and utilization of the drug-excipient chemical compatibility automated system. Int. J. Pharm. 359, 150-157, 2008.
10. Byrn SR; Xu W; Newman AW, Chemical reactivity in solid-state pharmaceuticals: formulation implications. Adv. Drug Del. Rev. 48, 115-136, 2001.
11. Jackson K; Young D; Pant S, Drug-excipient interactions and their affect on absorption. PSTT 3, (10), 336-345, 2000.
12. Monkhouse DC; Maderich A, Whither compatibility testing? Drug Dev. Ind. Pharm. 15, 2115-2130, 1989.
13. Crowley PJ, Excipients as stabilizers. Pharm. Sci. Technol. Today 2, 237-243, 1999.
14. Maulding HV; Zoglio MA; Pigois FE; Wagner M, Pharmaceutical heterogeneous systems IV: A kinetic approach to the stability screening of solid dosage forms containing aspirin. J. Pharm. Sci. 58, 1359-1362, 1969.
15. Kontny MJ; Grandolfi GP; Zografi G, Water vapor sorption of water-soluble substances: studies of crystalline solids below their critical relative humidities. Pharm. Res. 4, 104-112, 1987.
16. Callahan JC; Cleary GW; Elefant M; Kaplan G; Kensler T; Nash RA, Equilibrium moisture content of pharmaceutical excipients. Drug Dev. Ind. Pharm. 8, 355, 1982.
17. Hancock BC; Shamblin SL, Water vapor sorption by pharmaceutical sugars. Pharm. Sci. Technol. Today 1, 345-351, 1998.
18. Kontny MJ, Distribution of water in solid pharmaceutical systems. Drug Dev. Ind. Pharm. 14, 1991-2027, 1988.
19. Genton D; Kesselring UW, Effect of temperature and relative humidity on nitrazepam stability in solid state. J. Pharm. Sci. 66, 676-680, 1977.
20. Chemburkar PB; Smyth RD; Buehler JD; Shah PB; Joslin RS; Polk A; Reavey-Cantwell NH, Correlation between dissolution characteristics and absorption of methaqualone from solid dosage forms. J. Pharm. Sci. 65, 529-533, 1976.
21. Horhota ST; Burgio J; Lonski L; Rhodes CT, Effect of storage at specified temperature and humidity on properties of three directly compressible tablet formulations. J. Pharm. Sci. 65, 1746-1749, 1976.
22. Byrn SR; Kessler DW, The solid-state reactivity of the crystal forms hydrocortizone esters. Tetrahedron 43, 1335-1343, 1987.
23. Byrn SR; Lin CT, The effect of crystal packing and defects on desolvation of hydrate crystals of caffeine and L-(2)-1,4-cyclohexadiene-1-alanine. J. Am. Chem. Soc. 98, 4004-4005, 1976.
24. Byrn SR; Sutton PA; Tobias B; Frye J; Main P, Crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of prednisolone tertbutylacetate. J. Am. Chem. Soc. 110, 1609-1614, 1988.
25. Hartauer KJ; Arbuthnot GN; Baertschi SW; Johnson RA; Luke WD; Pearson NG; Rickard EC; Tingle CA; Tsang PKS; Wiens RE, Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product. Pharm. Dev. Technol. 5, 303-310, 2000.
26. Maillard LC, Action of amino acids on sugars. Formation of melanoidins in a methodical way. Comp. Rend. 154, 66-68, 1912.
27. Buxton PC; Jahnke R; Keady S, Degradation of glucose in the presence of electrolytes during heat sterilization. Eur. J. Pharm. Biopharm. 40, 172-175, 1994.
28. Monkhouse DC, Excipient compatibility possibilities and limitations in stability prediction. In Stability testing in the EC, Japan and the USA. Scientific and regulatory requirements, Crim W; Krummen K, Eds. Wissenschaftlidie Verlassgellschaft mbH: Stuttgart, 1993; pp 67-74.
29. Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS, Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets. Eur. J. Pharm. Biopharm. 73, (3), 404-413, 2009.
30. Gu L; Strickley RG; Chi LH; Chowhan ZT, Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: dry powder vs wet granulation. Pharm. Res. 7, (4), 379-83, 1990.
31. Ozdemir FA; Anilanmert B; Pekin M, Spectrophotometric investigation of the chemical compatibility of the anticancer drugs irinotecan-HCl and epirubicin-HCl in the same infusion solution. Cancer Chemother. Pharmacol. 56, 529-534, 2005.
32. Tong WQ; Zhang GGZ, Stability and excipient compatibility studies. Integrated Drug Product Development Process (3 day-course), University of Utah http://www.pharmacy.utah.edu/pharmaceutics/pdf/Stability.pdf, 2006.
33. Connors KA; Amidon GL; Stella VJ, Chemical Stability of Pharmaceuticals: A Handbook for Pharmacists. In 2nd ed.; John Wiley and Sons: New York, 1986; pp 93-94.
34. Waternnan KC; Adami RC; Alsante KM; Hong J; Landis MS; Lombardo F; Roberts CJ, Stabilization of pharmaceuticals to oxidative degradation. Pharm. Dev. Technol. 7, 1-32, 2002.
35. Mutalik S; Naha A; Usha AN; Ranjith AK; Musmade P; Manoj K; Anju P; Prasanna S, Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of Aceclofenac. Arch. Pharm. Res. 30, (2), 222-234, 2007.
36. deCarvalho LAEB; Marques MPM; Tomkinson J, Drug-excipient interactions in Ketoprofen: A vibrational spectroscopy study. Biopolymers 82, 420-424, 2006.
37. de Carvalho LAEB; Marques MPM; Tomkinson J, Drug-excipient interactions in ketoprofen: A vibrational spectroscopy study. Biopolymers 82, (4), 420-424, 2006.
38. Mura P; Manderioli A; Bramanti G; Furlanetto S; Pinzauti S, Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients. Int. J. Pharm. 119, 71-79, 1995.
39. Abdoh A; Al-Omari MM; Badwan AA; Jaber AMY, Amlodipine besylate-excipients interaction in solid dosage form. Pharm. Dev. Technol. 9, 15-24, 2004.
40. Serajuddin ATM; Thakur AB; Ghosal RN; Fakes MG; Ranadive SA; Morris KR; Varia SA, Selection of solid dosage form composition through drug-excipient compatibility testing. J. Pharm. Sci. 88, 696-704, 1999.
41. Eyjolfsson R, Lisinopril-lactose incompatibility. Drug Dev. Ind. Pharm. 24, 797-798, 1998.
42. Botha SA; Lotter AP, Compatibility study between oxprenolol hydrochloride, temazepam and tablet excipients using differntial scanning calorimetry. Drug Dev. Ind. Pharm. 16, 331-345, 1990.
43. Desai SR; Shaikh MM; Dharwadkar SR, Preformulation compatibility studies of etamsylate and fluconazole drugs with lacose by DSC. J. Therm. Anal. Cal. 71, 651-658, 2003.
44. Bertol CD; Cruz AP; Stulzer HK; Murakami FS; Silva MAS, Thermal decomposition kinetics and compatibility studies of primaquine under isothermal and non-isothermal conditions. J. Therm. Anal. Calorim., 102, 187-192, 2010.
45. Thumma S; Repka MA, Compatibility studies of promethazine hydrochloride with tablet excipients by means of thermal and non-thermal methods. Pharmazie 64, 183-189, 2009.
46. Wirth DD; Baertschi SW; Johnson RA; Maple SR; Miller MS; Hallenbeck DK; Gregg SM, Maillard Reaction of lactose and fluoxetine hydrochloride, a secondary amine. J. Pharm. Sci. 87, 31-39, 1998.
47. Schildcrout SA; Risley DS; Kleemann RL, Drug-excipient interactions of Seproxetine Maleate hemihydrate: Isothermal stress methods. Drug Dev. Ind. Pharm. 19, 1113-1130, 1993.
48. Mura P; Faucci MT; Manderioli A; Furlanetto S; Pinzauti S, Thermal analysis as a screening technique in preformulation studies of picotamide solid dosage forms. Drug Dev. Ind. Pharm. 24, 747-756, 1998.
49. Riaz M; Ami KH, Stability of aminophylline. Pak. J. Pharm. Sci. 6, 35-44, 1993.
50. Signoretti EC; Dell'utri A; Salvo AD; Donini L, Compatibility study between clenbuterol and tablet excipients using differential scanning calorimetry. Drug Dev. Ind. Pharm. 12, 603-620, 1986.
51. Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Shadbad MRS; Mojarrad JS; Robertson T; Roberts MS, Assessment of feasibility of Maillard reaction between Baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to preformulation studies. AAPS PharmSciTech 10, (2), 649-659, 2009.
52. Sarisuta N; Lawanprasert P; Puttipipatkhachorn S; Srikummoon K, The influence of drug-excipient and drug-polymer interactions on butt adhesive strength of Ranitidine Hydrochloride film-coated tablets. Drug Dev. Ind. Pharm. 32, 463-471, 2006.
53. Tonder ECV; Lotter AP; Botha SA, Compatibility study between Doxylamine Succinate with other drugs and excipients using differntial scanning calorimetry. Drug Dev. Ind. Pharm. 16, 2125-2133, 1990.
54. Flemming A; Picker-Freyer KM, Compaction of lactose drug mixtures: Quantification of the extent of incompatibility by FT-Raman spectroscopy. Eur. J. Pharm. Biopharm. 68, (3), 802-810, 2008.
55. Misra M; Misra AK; Panpalia GM, Interaction study between pefloxacin mesylate and some diluents using DSC supported with isothermal method. J. Therm. Anal. Cal. 89, 803-808, 2007.
56. Verma RK; Garg S, Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. J. Pharm. Biomed. Anal. 38, 633-644, 2005.
57. Agatonovic-Kustrin S; Markovic N; Ginic-Markovic M; Mangan M; Glass BD, Compatibility studies between mannitol and omeprazole sodium isomers. J. Pharm. Biomed. Anal. 48, 356-360, 2008.
58. Barboza F; Vecchia DD; Tagliari MP; Silva MAS; Stulzer HK, Differential scanning calorimetry as a screening technique in compatibility studies of Acyclovir extended release form ulations. Pharmaceut. Chem. J. 43, 363-368, 2009.
59. Jaminet F; Louis G, Influence de quelques lubrifiants sur la stabilite de l'Aspirine dans les comprimes. Pharm. Acta Helv. 43, 153-157, 1968.
60. Miller TA; York P, Pharmaceutical tablet lubrication. Int. J. Pharm. 41, 1-19, 1988.
61. Wissing S; Craig DQM; Barker SA; Moore WD, An investigation into the use of stepwise isothermal high sensitivity DSC as a means of detecting drug-excipient incompatibility. Int. J. Pharm. 199, (2), 141-150, 2000.
62. Harding L; Qi S; Hill G; Reading M; Craig DQM, The development of microthermal analysis and phototherm al m icrospectroscopy as novel approaches to drug-excipient compatibility studies. Int. J. Pharm. 354, 149-157, 2008.
63. Marini A; Berbenni V; Pegoretti M; Bruni G; Cofrancesco P; Sinistri C; Villa M, Drug excipient compatibility studies by physico chemical techniques. The case of atenolol. J. Therm. Anal. Cal. 73, 547-561, 2003.
64. Phipps MA; Winnike RA, Use of isothermal microcalorimetry in the early detection of potential drug formulation incompatibilities. Proc. Workshop Microcalorim. Energ. Mater., M1-M14, 1997.
65. Freire FD; Aragao CFS; Moura TF, Compatibility study between chlorpropamide and excipients in their physical mixtures. J. Therm. Anal. Calorim. 97, 355-357, 2009.
66. Cides LCS; Araújo AAS; Santos-Filho M; Matos JR, Thermal behaviour, compatibility study and decomposition kinetics of glimepiride under isothermal and non-isothermal conditions. J. Therm. Anal. Cal. 84, (2), 441-445, 2006.
67. Oliveira GGG; Ferraz HG; Matos JSR, Thermoanalytical study of glibenclamide and excipients. J. Therm. Anal. Cal. 79, 267-270, 2005.
68. Cheng W-T; Wang S-L; Lin S-Y, Solid-state interaction study on the captopril/lubricants systems accelerated by grinding process. J. Phys. Chem. 69, (4), 1007-1016, 2008.
69. Stulzer HK; Rodrigues PO; Cardoso TM; Matos JSR; Silva MAS, Compatibility studies between Captopril and pharmaceutical excipients used in tablets formulations. J. Therm. Anal. Cal. 91, 323-328, 2008.
70. Strickley RG; Visor GC; Lin L; Gu L, An unexpected pH effect on the stability of moexipril lyophilized powder. Pharm. Res. 6, 971-975, 1989.
71. El-Shattawy HH; Kildsig DO; Peck GE, C ephalexin-direct compression excipients: Preformulation stability screening using differential scanning calorimetry. Drug Dev. Ind. Pharm. 8, 897-909, 1982.
72. El-Shattawy HH; Kildsig DO; Peck GE, Erythromycin - Direct compression excipients: Preformulation stability screening using differential ccanning calorimetry. Drug Dev. Ind. Pharm. 8, 937-947, 1982.
73. El-Shattawy HH, Nalidixic acid - Direct compression excipients, preformulation stability screening using differential scanning calorimetry. Drug Dev. Ind. Pharm. 10, 491-504, 1984.
74. Jacobson H; Reier G, Application of differential thermal analysis to compatibility and stability problems in penicillin-stearic acid mixtures. J. Pharm. Sci. 58, 631-633, 1969.
75. Malan CEP; de Villiers MM; Lotter AP, Evaluation of compatibility of tablet excipients with albendazole and closantel using DSC and HPLC. Drug Dev. Ind. Pharm. 23, 533-537, 1997.
76. Cunha-Filho MSS; Martýnez-Pacheco R; Landin M, Compatibility of the antitumoral â-lapachone with different solid dosage forms excipients. J. Pharm. Biomed. Anal. 45, 590-598, 2007.
77. Doser KH; Glanzer K; Loffler U Pharmaceutical formulation for salts of monobasic acids with clopidogrel. 2007/0048370 A1, Mar. 1, 2007, 2007.
78. Voigt R; Pergande G; Keipert S, Comparative studies on the study of drug-excipient interactions with vapor pressure osmometry and equilibrium dialysis. Pharmazie 39, (11), 760-763, 1984.
79. Bruni G; Berbenni V; Milanese C; Girella A; Marini A, Drug-excipient compatibility studies in binary and ternary mixtures by physico-chemical techniques. J. Therm. Anal. Cal., 102, 193-201, 2010.
80. Kiss D; Zelkó R; Novák C; Éhen Z, Application of DSC and NIRS to study the compatibility of metronidazole with different pharmaceutical excipients. J. Therm. Anal. Cal. 84, 447-451, 2006.
81. Jin P; Madieh S; Augsburger LL, The solution and solid state stability and excipient compatibility of Parthenolide in Feverfew. AAPS PharmSciTech 8, E1-E6, 2007.
82. Indrayanto G; Mugihardjo; Handayani R, Compatibility study between famotidine and some excipients using differential scanning calorimetry. Drug Dev. Ind. Pharm. 20, 911-920, 1994.
83. Pignatello R; Ferro M; Puglisi G, Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions. AAPS PharmSciTech 3, (2), 1-11 [article 10], 2002. http://www.aapspharmscitech.org/articles/pt0302/pt030210/pt030210.pdf
84. Pignatello R; Ferro M; Guidi GD; Salemi G; Vandelli MA; Guccione S; Geppi M; Forte C; Puglisi G, Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100. Int. J. Pharm., (218), 27-42, 2001.
85. Gordon RE; VanKoevering CL; Reits DJ, Utilization of differential scanning calorimetry in the compatibility screening of ibuprofen with the stearate lubricants and construction of phase diagrams. Int. J. Pharm. 21, 99-105, 1984.
86. Pignatello R; Spadaro D; Vandelli MA; Forni F; Puglisi G, Characterization of the mechanism of interaction in Ibuprofen - Eudragit RL100 coevaporates. Drug Dev. Ind. Pharm. 30, 277-288, 2004.
87. Cotton ML; Wu DW; Vadas EB, Drug-excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy. Int. J. Pharm. 40, 129-142, 1987.
88. Devi MV; Babu PSSK, Drug-excipient interaction studies on enalapril maleate Int. J. Pharm. Excipients 2, 153-158 2000.
89. Dong Z; Choi DS, Hydroxypropyl methylcellulose acetate succinate: Potential drug-excipient incompatibility. AAPS PharmSciTech 9, (3), 991-997, 2008.
90. Teraoka R; Matsushima Y; Sugimoto I; Inoue K; Morita S-y; Kitagawa S, Effect of pharmaceutical excipients on the stability of Trichlormethiazide tablets under humid conditions. Chem. Pharm. Bull. 57, (12), 1343-1347, 2009.
91. Cory W.C; Harris C; Martinez S, Accelerated degradation of ibuprofen in tablets. Pharm. Dev. Technol., 15, 636-643, 2010.
92. Vecchio S; Rodante F; Tomassetti M, Thermal stability of disodium and calcium phosphomycin and the effects of the excipients evaluated by thermal analysis. J. Pharm. Biomed. Anal. 24, 1111-1123, 2001.
93. Lieberman HH; Lachman L; Schwartz JB, Pharmaceutical dosage forms: Tablets. In 2nd Edition ed.; Lieberman HH; Lachman L; Schwartz JB, Eds. Marcel Dekker, Inc.: NewYork, Basel, 1989; Vol. 1, p 557.
94. Sabnis S; Rege P; Block LH, Use of chitosan in compressed tablets of diclofenac sodium: Inhibition of drug release in an acidic environment. Pharm. Dev. Technol. 2, (3), 243-255, 1997.
95. Drebushchak VA; Shakhtshneider TP; Apenina SA; Medvedeva AS; Safronova LP; Boldyrev VV, Thermoanalytical investigation of drug-excipient interaction. Part II. Activated mixtures of piroxicam with cellulose and chitosan. J. Therm. Anal. Cal. 86, 303-309, 2006.
96. Kararli TT; Needham TE; Seul CJ; Finnegan PM, Solid state interaction of magnesium oxide and ibuprofen to form a salt. Pharm. Res. 6, 804-808, 1989.
97. Yuan L-C; Dahl TC; Oliyai R, Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil. Pharm. Res. 17, 1098-1103, 2000.
98. Moreton RC, Excipient interactions. In Excipient developemnt for pharmaceutical, biotechnology and drug delivery systems, Katdare A; Chaubal M, Eds. Informa Healthcare USA, Inc: New York, 2006; p 105.
99. Blaug S; Huang W, Interaction of dextroamphetamine sulfate with spraydried lactose. J. Pharm. Sci. 61, 1770-1775, 1972.
100. Hartauer KJ; Guillory JK, A comparison of diffuse reflectance FTIR spectroscopy and DSC in the characterization of a drug excipient interaction. Drug Dev. Ind. Pharm. 17, 617-630, 1991.
101. Santos AFO; BasílioJr ID; Souza FSd; Medeiros AFD; Pinto MF; Santana DPd; Macedo RO, Application of thermal analysis of binary mixtures with metformin. J. Therm. Anal. Cal. 93, (2), 361-364, 2008.
102. Cavatur R; Vemuri NM; Chrzan Z, Use of isothermal microcalorimetry in pharmaceutical preformulation studies part III. Evaluation of excipient compatibility of a new chemical entity. J. Therm. Anal. Cal. 78, 63-72, 2004.
103. Verloop Q; Marais AF; deVilliers MM; Liebenberg W, Compatibility of sennoside A and B with pharmaceutical excipients. Pharmazie 59, 728-730, 2004.
104. Ahlneck C; Zografi G, The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm. 62, 87-95, 1990.
105. Castello RA; Mattocks AM, Discoloration of tablets containing amines and lactose. J. Pharm. Sci. 51, 106-108, 1962.
106. Mroso PN; Li Wan Po A; Irwin WJ, Solid state stability of aspirin in the presence of exciplents: kinetic interpretation, modelling and prediction. J. Pharm. Sci. 71, 1096-1101, 1982.
107. Reepmeyer JC; Kirchhoefer RD, Isolation of salicylsalicylic acid, acetylsalicylsalicylic acid, and acetylsalicylic anhydride from aspirin tablets by extraction and high-pressure liquid chromatography. J. Pharm. Sci. 68, 1167-1169, 1979.
108. Mitrevej A; Hollenbeck RG, Influence of hydrophilic excipients on the interaction of aspirin and water. Int. J. Pharm. 14, 243-250, 1983.
109. Kornblum SS; Zoglio MA, Pharmaceutical heterogeneous systems I. Hydrolysis of aspirin in combination with tablet lubricants in an aqueous suspension. J. Pharm. Sci. 56, 1569-1575, 1967.
110. Nelson E; Eppich D; Carstensen JT, Topochemical decomposition patterns of aspirin. J. Pharm. Sci. 63, 755-757, 1974.
111. Troup AE; Mitchner H, Degradation of phenylephrine hydrochloride in tablet formulations containing aspirin. J. Pharm. Sci. 53, 375-379, 1964.
112. Jacobs AL; Dilatush AE; Weinstein S; Windheuser JJ, Formation of acetylcodeine from aspirin and codeine. J. Pharm. Sci. 55, 893-895, 1966.
113. Koshy KT; Troup AE; Duvall RN; Conwell RN; Shankle LL, Acetylation of acetaminophen in tablet formulations containing aspirin. J. Pharm. Sci. 56, 1117-1121, 1967.
114. Kartal A; Björkqvist M; Lehto V-P; Juppo AM; Marvola M; Sivén M, Compatibility of chewing gum excipients with the amino acid L-cysteine and stability of the active substance in directly compressed chewing gum formulation. J. Pharm. Pharmacol. 60, 1131-1138, 2008.
115. Zoglio MA; Maulding HV; Haller RM; Briggen S, Pharmaceutical heterogeneous systems III. Inhibition of stearate lubricant induced degradation of aspirin by the use of certain organic acids. J. Pharm. Sci. 57, 1877-1880, 1968.
116. Garg A; Singh S; Rao VU; Bindu K; Balasubramaniam J, Solid State Interaction of Raloxifene HCl with Different Hydrophilic Carriers During Co-grinding and its Effect on Dissolution Rate. Drug Dev. Ind. Pharm. 35, 455-470, 2009.
117. Chan AS, Fluoride stability in dicalcium phosphate dihydrate composition. United States Patent 5037636, 1991.
118. Thakur AB; Chen X; Bugay DE; Serajuddin ATM, Solid state incompatibility of dicalcium phosphate dihydrate with the sodium salt of a poorly water-soluble drug. Pharm. Res. 11 (Supl.), S166, 1994.
119. Stroyer A; McGinity JW; Leopard CS, Solid State Interactions between the Proton Pump Inhibitor Omeprazole and Various Enteric Coating Polymers. J. Pharm. Sci. 95, 1342-1353, 2006.
120. Rezende RLO; Santoro MIRM; Matos JR, Stability and compatibility study of Enalapril maleate using thermoanalytical techniques. J. Therm. Anal. Cal. 93, 881-886, 2008.
121. Jun HW; Whitworth CW; Luzzi LA, Decomposition of aspirin in polyethylene glycols. J. Pharm. Sci. 61, 1160-1162, 1972.
122. Whitworth CW; Luzzi LA; Thompson BB; Jun HW, Stability of aspirin in liquid and semisolid bases II: Effect of fatty additives on stability in a polyethylene glycol base. J. Pharm. Sci. 62, 1372-1374, 1973.
123. Ha E; Wang W; Wang J, Peroxide formation in polysorbate 80 and protein stability. J. Pharm. Sci. 91, 2252-2264, 2002.
124. Ilium L, Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15, 1326-1331, 1998.
125. Patel H; Stalcup A; Dansereau R; Sakr A, The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets. Int. J. Pharm. 264, 35-43, 2003.
126. Kumar V; Shah RP; Malik S; Singh S, Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation. J. Pharm. Biomed. Anal. 49, 880-888, 2009.
127. Lira AM; Araujo AAS; Basilio IDJ; Santos BLL; Santana DP; Macedo RO, Compatibility studies of lapachol with pharmaceutical excipients for the development of topical formulations. Thermochim. Acta 457, (1-2), 1-6, 2007.
128. Moyano MA; Broussalis AM; Segall AI, Thermal analysis of lipoic acid and evaluation of the compatibility with excipientes. J. Therm. Anal. Calorim., 99, 631-637, 2010.
129. Alexander KS; Pudipeddi M; Parker GA, Stability of hydralazine hydrochloride syrup compounded from tablets. Am. J. Hosp. Pharm. 50, 683-686, 1993.
130. Munjal M; Stodghill SP; ElSohly MA; Repka MA, Polym eric system s for am orphou s 9-tetrahydrocannabinol produced by a hot-melt method. Part I: Chemical and thermal stability during processing. J. Pharm. Sci. 95, (8), 1841-1853, 2006.